Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.
Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.
Shares of Allurion Technologies ( ALUR, Financials) surged 185% to $10.54 in midday trading after the company announced plans ...
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
27,587 people played the daily Crossword recently. Can you solve it faster than others?27,587 people played the daily Crossword recently. Can you solve it faster than others?